1Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California.
2Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, Arizona; and.
J Neurosurg. 2024 Jun 14;141(6):1739-1746. doi: 10.3171/2024.4.JNS24121. Print 2024 Dec 1.
The incidence of chronic subdural hematomas (cSDHs) is expected to climb precipitously in the coming decades because of the aging populous. Neurological weakness is one of the most common presenting neurological symptoms of cSDH. Yet, the recovery rates of motor strength recovery are seldom documented, as neurological outcomes have predominantly focused on broader functional assessment scores or mortality. In this study, the authors performed one of the first detailed analyses on functional motor weakness and recovery in patients who underwent cSDH evacuation.
Patients who underwent evacuation of a cSDH at a tertiary academic medical center between November 2013 and December 2021 were retrospectively identified using ICD-9 and ICD-10 billing codes. The presence of focal motor weakness was subcategorized by location as upper extremity (UE) or lower extremity (LE). Postoperative improvement, worsening, or resolution of weakness was recorded at the time of discharge. Statistical analysis included univariate and backward stepwise multivariable logistic regression modeling.
A total of 311 patients were included in the analysis. Patients were significantly more likely to experience UE weakness than LE weakness (29% vs 18%, p < 0.001). Forty-one percent (43/104) had both UE and LE weakness present. Risk factors for the development of focal motor weakness at the time of presentation were older age (OR 1.02, p = 0.03), increased cSDH size (OR 1.04, p = 0.02), and the presence of a unilateral cSDH (OR 2.32, p = 0.008). The majority of patients (68%, 71/104) experienced motor strength improvement following cSDH evacuation, with 58% (60/104) having complete resolution of weakness. Multivariable logistic regression analysis revealed that longer symptom duration was associated with lower rates of improvement (OR 0.96, p = 0.024). Older age was also associated with reduced resolution of weakness (OR 0.96, p = 0.02).
This study represents one of the first in-depth analyses investigating the rates of motor strength weakness and recovery following cSDH evacuation. Nearly two-thirds of all patients had complete resolution of their weakness by the time of discharge, and more than three-quarters had partial improvement. Risk factors for impaired neurological recovery were longer symptom duration prior to treatment and older age.
由于人口老龄化,预计未来几十年慢性硬膜下血肿(cSDH)的发病率将急剧上升。神经无力是 cSDH 最常见的神经表现症状之一。然而,运动力量恢复的恢复率很少被记录下来,因为神经学结果主要集中在更广泛的功能评估评分或死亡率上。在这项研究中,作者对在三级学术医疗中心接受 cSDH 清除术的患者的功能性运动无力和恢复进行了首次详细分析之一。
使用 ICD-9 和 ICD-10 计费代码,回顾性地确定了 2013 年 11 月至 2021 年 12 月期间在一家三级学术医疗中心接受 cSDH 清除术的患者。根据位置将局灶性运动无力分为上肢(UE)或下肢(LE)。出院时记录无力的改善、恶化或消退。统计分析包括单变量和向后逐步多变量逻辑回归建模。
共纳入 311 例患者进行分析。与 LE 无力相比,患者 UE 无力更常见(29%比 18%,p<0.001)。41%(43/104)同时存在 UE 和 LE 无力。发病时出现局灶性运动无力的危险因素包括年龄较大(OR 1.02,p=0.03)、cSDH 增大(OR 1.04,p=0.02)和单侧 cSDH 存在(OR 2.32,p=0.008)。大多数患者(68%,71/104)在 cSDH 清除后运动力量得到改善,58%(60/104)的患者完全消除了无力。多变量逻辑回归分析显示,症状持续时间较长与改善率较低相关(OR 0.96,p=0.024)。年龄较大也与无力的缓解程度降低有关(OR 0.96,p=0.02)。
这项研究是首次对 cSDH 清除术后运动力量无力和恢复率进行深入分析之一。几乎三分之二的患者在出院时完全消除了无力,超过四分之三的患者有部分改善。神经恢复受损的危险因素是治疗前症状持续时间较长和年龄较大。